ID   NMNA_DROME              Reviewed;         389 AA.
AC   Q9VC03; A0A0B4KHH7; Q7KS06; Q8T405;
DT   18-JUN-2025, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 4.
DT   28-JAN-2026, entry version 187.
DE   RecName: Full=Nicotinamide-nucleotide adenylyltransferase {ECO:0000255|RuleBase:RU362021};
DE            EC=2.7.7.1 {ECO:0000255|RuleBase:RU362021, ECO:0000269|PubMed:17132048, ECO:0000269|PubMed:19403820, ECO:0000269|PubMed:26616331};
DE            EC=2.7.7.18 {ECO:0000255|RuleBase:RU362021};
DE   AltName: Full=Nicotinamide mononucleotide adenylyltransferase {ECO:0000312|FlyBase:FBgn0039254};
DE            Short=dNmnat {ECO:0000312|FlyBase:FBgn0039254};
GN   Name=Nmnat {ECO:0000303|PubMed:17132048,
GN   ECO:0000312|FlyBase:FBgn0039254};
GN   ORFNames=CG13645 {ECO:0000312|FlyBase:FBgn0039254};
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;
OC   Neoptera; Endopterygota; Diptera; Brachycera; Muscomorpha; Ephydroidea;
OC   Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227 {ECO:0000312|Proteomes:UP000000803};
RN   [1] {ECO:0000312|Proteomes:UP000000803}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley {ECO:0000312|Proteomes:UP000000803};
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X., Brandon R.C.,
RA   Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D., Wan K.H., Doyle C.,
RA   Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G., Abril J.F., Agbayani A.,
RA   An H.-J., Andrews-Pfannkoch C., Baldwin D., Ballew R.M., Basu A.,
RA   Baxendale J., Bayraktaroglu L., Beasley E.M., Beeson K.Y., Benos P.V.,
RA   Berman B.P., Bhandari D., Bolshakov S., Borkova D., Botchan M.R., Bouck J.,
RA   Brokstein P., Brottier P., Burtis K.C., Busam D.A., Butler H., Cadieu E.,
RA   Center A., Chandra I., Cherry J.M., Cawley S., Dahlke C., Davenport L.B.,
RA   Davies P., de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I.,
RA   Dietz S.M., Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C.,
RA   Dunn P., Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S.,
RA   Fleischmann W., Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M.,
RA   Glasser K., Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J., Hostin D.,
RA   Houston K.A., Howland T.J., Wei M.-H., Ibegwam C., Jalali M., Kalush F.,
RA   Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A., Kimmel B.E., Kodira C.D.,
RA   Kraft C.L., Kravitz S., Kulp D., Lai Z., Lasko P., Lei Y., Levitsky A.A.,
RA   Li J.H., Li Z., Liang Y., Lin X., Liu X., Mattei B., McIntosh T.C.,
RA   McLeod M.P., McPherson D., Merkulov G., Milshina N.V., Mobarry C.,
RA   Morris J., Moshrefi A., Mount S.M., Moy M., Murphy B., Murphy L.,
RA   Muzny D.M., Nelson D.L., Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R.,
RA   Pacleb J.M., Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V.,
RA   Reese M.G., Reinert K., Remington K., Saunders R.D.C., Scheeler F.,
RA   Shen H., Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E., Svirskas R.,
RA   Tector C., Turner R., Venter E., Wang A.H., Wang X., Wang Z.-Y.,
RA   Wassarman D.A., Weinstock G.M., Weissenbach J., Williams S.M., Woodage T.,
RA   Worley K.C., Wu D., Yang S., Yao Q.A., Ye J., Yeh R.-F., Zaveri J.S.,
RA   Zhan M., Zhang G., Zhao Q., Zheng L., Zheng X.H., Zhong F.N., Zhong W.,
RA   Zhou X., Zhu S.C., Zhu X., Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M.,
RA   Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [2] {ECO:0000312|Proteomes:UP000000803}
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley {ECO:0000312|Proteomes:UP000000803};
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q., Stapleton M.,
RA   Yamada C., Ashburner M., Gelbart W.M., Rubin G.M., Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a systematic
RT   review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [3] {ECO:0000312|EMBL:AAL90149.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM D).
RC   STRAIN=Berkeley {ECO:0000312|EMBL:AAL90149.1};
RC   TISSUE=Testis {ECO:0000312|EMBL:AAL90149.1};
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M., George R.A.,
RA   Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H., Rubin G.M.,
RA   Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [4] {ECO:0000312|EMBL:ABV82132.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A).
RC   TISSUE=Testis {ECO:0000312|EMBL:ABV82132.1};
RA   Stapleton M., Carlson J., Frise E., Kapadia B., Park S., Wan K., Yu C.,
RA   Celniker S.;
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000305}
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, TISSUE SPECIFICITY,
RP   DISRUPTION PHENOTYPE, AND MUTAGENESIS OF HIS-61; TRP-129 AND ARG-255.
RX   PubMed=17132048; DOI=10.1371/journal.pbio.0040416;
RA   Zhai R.G., Cao Y., Hiesinger P.R., Zhou Y., Mehta S.Q., Schulze K.L.,
RA   Verstreken P., Bellen H.J.;
RT   "Drosophila NMNAT maintains neural integrity independent of its NAD
RT   synthesis activity.";
RL   PLoS Biol. 4:e416-e416(2006).
RN   [6] {ECO:0000305}
RP   FUNCTION, INDUCTION BY PROTEOTOXIC STRESS, DOMAIN, AND MUTAGENESIS OF
RP   HIS-61; TRP-129 AND ARG-255.
RX   PubMed=18344983; DOI=10.1038/nature06721;
RA   Zhai R.G., Zhang F., Hiesinger P.R., Cao Y., Haueter C.M., Bellen H.J.;
RT   "NAD synthase NMNAT acts as a chaperone to protect against
RT   neurodegeneration.";
RL   Nature 452:887-891(2008).
RN   [7] {ECO:0000305}
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=19403820; DOI=10.1523/jneurosci.5469-08.2009;
RA   Sasaki Y., Vohra B.P., Lund F.E., Milbrandt J.;
RT   "Nicotinamide mononucleotide adenylyl transferase-mediated axonal
RT   protection requires enzymatic activity but not increased levels of neuronal
RT   nicotinamide adenine dinucleotide.";
RL   J. Neurosci. 29:5525-5535(2009).
RN   [8] {ECO:0000305}
RP   FUNCTION, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF TRP-129 AND ARG-255.
RX   PubMed=21596138; DOI=10.1016/j.mcn.2011.05.002;
RA   Wen Y., Parrish J.Z., He R., Zhai R.G., Kim M.D.;
RT   "Nmnat exerts neuroprotective effects in dendrites and axons.";
RL   Mol. Cell. Neurosci. 48:1-8(2011).
RN   [9] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=22425156; DOI=10.1016/j.cub.2012.01.065;
RA   Fang Y., Soares L., Teng X., Geary M., Bonini N.M.;
RT   "A novel Drosophila model of nerve injury reveals an essential role of
RT   Nmnat in maintaining axonal integrity.";
RL   Curr. Biol. 22:590-595(2012).
RN   [10] {ECO:0000305}
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, ALTERNATIVE SPLICING,
RP   INDUCTION BY HEAT SHOCK AND PROTEOTOXIC STRESS, NUCLEAR LOCALISAION SIGNAL,
RP   AND MUTAGENESIS OF LYS-380.
RX   PubMed=26616331; DOI=10.1038/ncomms10057;
RA   Ruan K., Zhu Y., Li C., Brazill J.M., Zhai R.G.;
RT   "Alternative splicing of Drosophila Nmnat functions as a switch to enhance
RT   neuroprotection under stress.";
RL   Nat. Commun. 6:10057-10057(2015).
CC   -!- FUNCTION: Catalyzes the formation of NAD(+) from nicotinamide
CC       mononucleotide (NMN) and ATP (PubMed:17132048, PubMed:19403820).
CC       Essential for viability (PubMed:17132048). Stress-response chaperone
CC       protein that prevents toxic aggregation of proteins and promotes
CC       proteasome-mediated degradation of misfolded proteins; this is
CC       independent of its NAD(+) synthesis activity (PubMed:18344983).
CC       Neuroprotective in response to toxic protein aggregation, for example
CC       by overexpressed Atx-1/ataxin-1 (PubMed:18344983). Required for
CC       maintenance and integrity of mature neurons, protecting them from
CC       neuronal activity-induced neurodegeneration (PubMed:17132048,
CC       PubMed:19403820). Required for the maintenance of axonal and dendritic
CC       integrity in both central and peripheral neurons (PubMed:21596138,
CC       PubMed:22425156). Chaperone function and neuroprotective roles are
CC       largely independent of NAD(+) synthesis activity (PubMed:17132048,
CC       PubMed:18344983, PubMed:21596138). {ECO:0000269|PubMed:17132048,
CC       ECO:0000269|PubMed:18344983, ECO:0000269|PubMed:19403820,
CC       ECO:0000269|PubMed:21596138, ECO:0000269|PubMed:22425156}.
CC   -!- FUNCTION: [Isoform C]: Catalyzes the formation of NAD(+) from
CC       nicotinamide mononucleotide (NMN) and ATP (PubMed:26616331). Has, or
CC       stimulates, chaperone holdase activity but not refoldase activity
CC       (PubMed:26616331). Does not have neuroprotective properties and may
CC       stimulate apoptosis and neurodegeneration in response to toxic protein
CC       aggregates (PubMed:26616331). {ECO:0000269|PubMed:26616331}.
CC   -!- FUNCTION: [Isoform D]: Catalyzes the formation of NAD(+) from
CC       nicotinamide mononucleotide (NMN) and ATP (PubMed:26616331). Has, or
CC       stimulates, chaperone holdase and refoldase activity (PubMed:26616331).
CC       Neuroprotective and reduces the toxic load of protein aggregates,
CC       preventing apoptosis and neurodegeneration (PubMed:26616331). Promotes
CC       clearance of nuclear misfolded protein aggregates (PubMed:26616331).
CC       {ECO:0000269|PubMed:26616331}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=beta-nicotinamide D-ribonucleotide + ATP + H(+) = diphosphate
CC         + NAD(+); Xref=Rhea:RHEA:21360, ChEBI:CHEBI:14649, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57540; EC=2.7.7.1;
CC         Evidence={ECO:0000255|RuleBase:RU362021, ECO:0000269|PubMed:17132048,
CC         ECO:0000269|PubMed:19403820, ECO:0000269|PubMed:26616331};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:21361;
CC         Evidence={ECO:0000269|PubMed:19403820, ECO:0000269|PubMed:26616331};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=nicotinate beta-D-ribonucleotide + ATP + H(+) = deamido-NAD(+)
CC         + diphosphate; Xref=Rhea:RHEA:22860, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57502,
CC         ChEBI:CHEBI:58437; EC=2.7.7.18;
CC         Evidence={ECO:0000255|RuleBase:RU362021};
CC   -!- PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; NAD(+) from
CC       nicotinamide D-ribonucleotide: step 1/1.
CC       {ECO:0000255|RuleBase:RU362021, ECO:0000269|PubMed:17132048,
CC       ECO:0000269|PubMed:19403820, ECO:0000269|PubMed:26616331}.
CC   -!- PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; deamido-NAD(+)
CC       from nicotinate D-ribonucleotide: step 1/1. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17132048}. Cytoplasm
CC       {ECO:0000269|PubMed:17132048, ECO:0000269|PubMed:19403820}. Presynaptic
CC       active zone {ECO:0000269|PubMed:17132048}. Note=Localizes predominantly
CC       to the cytoplasm (PubMed:19403820). Present in neuronal and muscle cell
CC       nuclei (PubMed:17132048). Punctate localization at the presynaptic
CC       active zone colocalizing with brp/nc82 active zone marker in
CC       photoreceptors and other neurons (PubMed:17132048).
CC       {ECO:0000269|PubMed:17132048, ECO:0000269|PubMed:19403820}.
CC   -!- SUBCELLULAR LOCATION: [Isoform C]: Nucleus
CC       {ECO:0000269|PubMed:26616331}. Note=Associates with nuclear misfolded
CC       protein aggregates. {ECO:0000269|PubMed:26616331}.
CC   -!- SUBCELLULAR LOCATION: [Isoform D]: Cytoplasm
CC       {ECO:0000269|PubMed:26616331}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=4;
CC         Comment=A number of isoforms are produced (PubMed:26616331).
CC         Alternative splicing produces 2 mRNAs, RA and RB (PubMed:26616331).
CC         Isoforms A and C are expressed from RA, with isoform C using the Met-
CC         32 alternative initiation codon (PubMed:26616331). Isoforms B and D
CC         are expressed from RB, with isoform D using the Met-32 alternative
CC         initiation codon (PubMed:26616331). Isoforms C and D are more
CC         efficiently expressed due to a highly efficient Kozak consensus
CC         sequence flanking the Met-32 alternative initiation codon
CC         (PubMed:26616331). Alternative splicing to produce RB is stimulated
CC         under stress in a cell type specific manner (PubMed:26616331). Under
CC         stress, neurons preferentially produce RB while glial cells produce
CC         RA (PubMed:26616331). {ECO:0000269|PubMed:26616331};
CC       Name=A {ECO:0000312|FlyBase:FBgn0039254};
CC         IsoId=Q9VC03-1; Sequence=Displayed;
CC       Name=B {ECO:0000312|FlyBase:FBgn0039254};
CC         IsoId=Q9VC03-2; Sequence=VSP_062554, VSP_062555;
CC       Name=C {ECO:0000312|FlyBase:FBgn0039254};
CC         IsoId=Q9VC03-3; Sequence=VSP_062553;
CC       Name=D {ECO:0000312|FlyBase:FBgn0039254};
CC         IsoId=Q9VC03-4; Sequence=VSP_062553, VSP_062554, VSP_062555;
CC   -!- TISSUE SPECIFICITY: Abundantly expressed in neuronal and muscle cells
CC       (PubMed:17132048). Present at relatively low levels at the
CC       neuromuscular junction (PubMed:17132048). Expressed in the eye; present
CC       in photoreceptor cells and various neurons in the lamina cortex and
CC       medulla cortex and at low levels in the lamina (PubMed:17132048).
CC       {ECO:0000269|PubMed:17132048}.
CC   -!- INDUCTION: Overall expression and the relative expression of the
CC       alternatively spliced RB mRNA (encoding isoforms B and D) is increased
CC       by heat shock (acute stress) and proteotoxic stress (chronic stress).
CC       {ECO:0000269|PubMed:18344983, ECO:0000269|PubMed:26616331}.
CC   -!- DOMAIN: The N-terminal region, which includes the putative catalytic
CC       motif, is not required for chaperone activity.
CC       {ECO:0000269|PubMed:18344983}.
CC   -!- DOMAIN: The C-terminal region, which includes a putative ATP binding
CC       motif, is required for efficient chaperone activity.
CC       {ECO:0000269|PubMed:18344983}.
CC   -!- DISRUPTION PHENOTYPE: Larval lethal at first instar stage
CC       (PubMed:17132048). Dendrites of the dorsal class IV neuron develop
CC       normally up to the first instar larval stage (PubMed:21596138). Sensory
CC       neurons in the ventral nerve cord display extensive axon fragmentation
CC       and near complete loss of axon termini (PubMed:21596138). RNAi-mediated
CC       knockdown in chemosensory neurons of the gustatory system in the wing,
CC       leg, and labellum results in wing neurons that develop normally up to
CC       eclosion but undergo rapid spontaneous degeneration in the first few
CC       days post eclosion characterized by loss of axonal mitochondria and
CC       axonal fragmentation that starts in the distal axons and progresses
CC       retrogradely towards the proximal axons (PubMed:22425156).
CC       {ECO:0000269|PubMed:17132048, ECO:0000269|PubMed:21596138,
CC       ECO:0000269|PubMed:22425156}.
CC   -!- SIMILARITY: Belongs to the eukaryotic NMN adenylyltransferase family.
CC       {ECO:0000255|RuleBase:RU362021}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE014297; AAF56373.4; -; Genomic_DNA.
DR   EMBL; AE014297; AAN14028.2; -; Genomic_DNA.
DR   EMBL; AE014297; AGB96322.1; -; Genomic_DNA.
DR   EMBL; AE014297; QCD25207.1; -; Genomic_DNA.
DR   EMBL; AY089411; AAL90149.1; -; mRNA.
DR   EMBL; BT030750; ABV82132.1; -; mRNA.
DR   RefSeq; NP_001262942.1; NM_001276013.2. [Q9VC03-3]
DR   RefSeq; NP_001356924.1; NM_001369970.1. [Q9VC03-4]
DR   RefSeq; NP_651315.2; NM_143058.1. [Q9VC03-1]
DR   RefSeq; NP_733064.2; NM_170185.1. [Q9VC03-2]
DR   AlphaFoldDB; Q7KS06; -.
DR   SMR; Q9VC03; -.
DR   FunCoup; Q9VC03; 687.
DR   IntAct; Q9VC03; 2.
DR   STRING; 7227.FBpp0084124; -.
DR   PaxDb; 7227-FBpp0084124; -.
DR   DNASU; 42987; -.
DR   EnsemblMetazoa; FBtr0084749; FBpp0084124; FBgn0039254.
DR   GeneID; 42987; -.
DR   KEGG; dme:Dmel_CG13645; -.
DR   UCSC; CG13645-RA; d. melanogaster. [Q9VC03-1]
DR   UCSC; CG13645-RB; d. melanogaster.
DR   AGR; FB:FBgn0039254; -.
DR   CTD; 42987; -.
DR   FlyBase; FBgn0039254; Nmnat.
DR   VEuPathDB; VectorBase:FBgn0039254; -.
DR   eggNOG; KOG3199; Eukaryota.
DR   HOGENOM; CLU_033366_3_0_1; -.
DR   OMA; HFDYELN; -.
DR   OrthoDB; 422187at2759; -.
DR   BRENDA; 2.7.7.1; 1994.
DR   BRENDA; 2.7.7.18; 1994.
DR   Reactome; R-DME-196807; Nicotinate metabolism.
DR   UniPathway; UPA00253; UER00332.
DR   UniPathway; UPA00253; UER00600.
DR   BioGRID-ORCS; 42987; 1 hit in 3 CRISPR screens.
DR   Proteomes; UP000000803; Chromosome 3R.
DR   Bgee; FBgn0039254; Expressed in outer photoreceptor cell (Drosophila) in insect head and 118 other cell types or tissues.
DR   ExpressionAtlas; Q9VC03; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IDA:FlyBase.
DR   GO; GO:0005739; C:mitochondrion; ISS:FlyBase.
DR   GO; GO:0031594; C:neuromuscular junction; IDA:FlyBase.
DR   GO; GO:0043025; C:neuronal cell body; IDA:FlyBase.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0048786; C:presynaptic active zone; IMP:FlyBase.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0000309; F:nicotinamide-nucleotide adenylyltransferase activity; IDA:FlyBase.
DR   GO; GO:0004515; F:nicotinate-nucleotide adenylyltransferase activity; ISS:FlyBase.
DR   GO; GO:0051082; F:unfolded protein binding; IDA:FlyBase.
DR   GO; GO:0009435; P:NAD+ biosynthetic process; IBA:GO_Central.
DR   GO; GO:0034355; P:NAD+ biosynthetic process via the salvage pathway; IMP:FlyBase.
DR   GO; GO:1900074; P:negative regulation of neuromuscular synaptic transmission; IDA:FlyBase.
DR   GO; GO:1990535; P:neuron projection maintenance; IMP:FlyBase.
DR   GO; GO:0045494; P:photoreceptor cell maintenance; IMP:FlyBase.
DR   CDD; cd09286; NMNAT_Eukarya; 1.
DR   FunFam; 3.40.50.620:FF:000191; Nicotinamide-nucleotide adenylyltransferase; 1.
DR   Gene3D; 3.40.50.620; HUPs; 1.
DR   InterPro; IPR004821; Cyt_trans-like.
DR   InterPro; IPR051182; Euk_NMN_adenylyltrnsfrase.
DR   InterPro; IPR005248; NadD/NMNAT.
DR   InterPro; IPR045094; NMNAT_euk.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   NCBIfam; TIGR00482; nicotinate (nicotinamide) nucleotide adenylyltransferase; 1.
DR   PANTHER; PTHR12039; NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE; 1.
DR   PANTHER; PTHR12039:SF0; NICOTINAMIDE-NUCLEOTIDE ADENYLYLTRANSFERASE; 1.
DR   Pfam; PF01467; CTP_transf_like; 1.
DR   SUPFAM; SSF52374; Nucleotidylyl transferase; 1.
PE   1: Evidence at protein level;
KW   Alternative initiation; Alternative splicing; ATP-binding; Cell projection;
KW   Cytoplasm; NAD; Neurodegeneration; Nucleotide-binding;
KW   Nucleotidyltransferase; Nucleus; Pyridine nucleotide biosynthesis;
KW   Reference proteome; Synapse; Transferase.
FT   CHAIN           1..389
FT                   /note="Nicotinamide-nucleotide adenylyltransferase"
FT                   /id="PRO_0000462308"
FT   MOTIF           380..383
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000269|PubMed:26616331"
FT   VAR_SEQ         1..31
FT                   /note="Missing (in isoform C and isoform D)"
FT                   /id="VSP_062553"
FT   VAR_SEQ         287..297
FT                   /note="KYITDAVRPNH -> RDAPAPTECDS (in isoform B and isoform
FT                   D)"
FT                   /id="VSP_062554"
FT   VAR_SEQ         298..389
FT                   /note="Missing (in isoform B and isoform D)"
FT                   /id="VSP_062555"
FT   MUTAGEN         61
FT                   /note="H->A: Abolishes adenylyltransferase activity. Has no
FT                   effect on chaperone activity."
FT                   /evidence="ECO:0000269|PubMed:17132048,
FT                   ECO:0000269|PubMed:18344983"
FT   MUTAGEN         129
FT                   /note="W->G: Reduces adenylyltransferase activity; probably
FT                   by disrupting substrate binding. Abolishes NMN
FT                   adenylyltransferase activity; when associated with A-255.
FT                   Has no effect on chaperone activity or on neuronal cell
FT                   dendrite maintenance; when associated with A-255."
FT                   /evidence="ECO:0000269|PubMed:17132048,
FT                   ECO:0000269|PubMed:18344983, ECO:0000269|PubMed:21596138"
FT   MUTAGEN         255
FT                   /note="R->A: Reduces NMN adenylyltransferase activity;
FT                   probably by disrupting substrate binding. Abolishes NMN
FT                   adenylyltransferase activity; when associated with G-129.
FT                   Has no effect on chaperone activity or on neuronal cell
FT                   dendrite maintenance; when associated with G-129."
FT                   /evidence="ECO:0000269|PubMed:17132048,
FT                   ECO:0000269|PubMed:18344983, ECO:0000269|PubMed:21596138"
FT   MUTAGEN         380
FT                   /note="K->R: Switches localization from nuclear to
FT                   cytoplasmic."
FT                   /evidence="ECO:0000269|PubMed:26616331"
SQ   SEQUENCE   389 AA;  43796 MW;  32D04D9E02803B86 CRC64;
     MIVKISWPKN NITSECFRRF GSFKRRSKSK KMSAFIEETK SLLPRIAFIA CGCFSPPTPM
     HLRMFEIAKD HFEMQGTHRV VGGIISPTHD SYGKKGLASA LDRCAMVKLA TQSSNWIRLS
     DWEVHQNQWM RTQAVLQHHQ NYINNHINSG GGGGDDGENT HLPGWLPRGL HDSRDPVHLK
     LLCGADLLES FAVPGLWAEA DIEDIVANHG LVVITRAGSN PGKFIFDSDI LTKYQSNITL
     ITNWVPNEVS STLIRRLLGR GQSVKYLLDD LVLEYIKRQR LFNFKSKYIT DAVRPNHLLF
     NHAYTDNNKN ANSYSIGDQL EQDMDESDTP SPQLQHTPTS RVFCCGEVPL RGSKVLRSGP
     GQAVQVITMQ ADEKEESQAK KQKISQVQL
//
